UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------
FORM 10-K/A
Annual Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
-----------------
For the fiscal year ended December 31, 1996
Commission File number 0-19278
----------------- -------
OSTEOTECH, INC.
(Exact name of registrant as specified in its charter)
Delaware 13-3357370
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
51 James Way, Eatontown, New Jersey 07724
- -------------------------------------------------------------------
(address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (908) 542-2800
Securities registered pursuant to Section 12(b) of the Act: None
Securities registered pursuant to Section 12(g) of the Act:
Common Stock, $.01 Par Value
(Title of class)
Preferred Stock Purchase Rights
(Title of class)
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No
Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained, to the
best of registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. X
The aggregate market value of the Common Stock, par value $.01 per share,
held by non-affiliates based upon the reported last sale price of the Common
Stock on March 3, 1997 was approximately $60,079,950.
As of March 3, 1997, there were 7,909,787 shares of Common Stock, par value
$.01 per share, outstanding.
The Index to Exhibits appears on page E-1.
Documents Incorporated by Reference
The registrant's definitive 1997 Proxy Statement which will be filed
pursuant to Regulation 14A is incorporated by reference into Part III of this
Annual Report on Form 10-K.
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
Dated: May 5, 1997
OSTEOTECH, INC.
By: /s/MICHAEL J. JEFFRIES
Michael J. Jeffries
Executive Vice
President, Chief
Operating Officer,
Chief Financial Officer
(Principal Financial
Officer and Principal
Accounting Officer),
Secretary and Director
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Osteotech,
Inc.'s Balance Sheet as of December 31, 1996 and its Consolidated Statement of
Operations for the twelve months ended December 31, 1996 and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
<CIK> 0000874734
<NAME> Osteotech, Inc.
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-END> DEC-31-1996
<CASH> $7,290,000
<SECURITIES> 1,987,000
<RECEIVABLES> 6,443,000
<ALLOWANCES> 163,000
<INVENTORY> 729,000
<CURRENT-ASSETS> 19,931,000
<PP&E> 15,386,000
<DEPRECIATION> 7,216,000
<TOTAL-ASSETS> 31,483,000
<CURRENT-LIABILITIES> 7,658,000
<BONDS> 840,000
0
0
<COMMON> 78,000
<OTHER-SE> 30,175,000
<TOTAL-LIABILITY-AND-EQUITY> 31,483,000
<SALES> 2,481,000
<TOTAL-REVENUES> 34,895,000
<CGS> 2,414,000
<TOTAL-COSTS> 33,146,000
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 17,000
<INTEREST-EXPENSE> 232,000
<INCOME-PRETAX> 2,020,000
<INCOME-TAX> 2,344,000
<INCOME-CONTINUING> (324,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (324,000)
<EPS-PRIMARY> (.04)
<EPS-DILUTED> (.04)
</TABLE>
